Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter
- PMID: 33691086
- PMCID: PMC8058485
- DOI: 10.1016/j.ymthe.2021.03.001
Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter
Figures
Comment on
-
Telomerase therapy attenuates cardiotoxic effects of doxorubicin.Mol Ther. 2021 Apr 7;29(4):1395-1410. doi: 10.1016/j.ymthe.2020.12.035. Epub 2021 Jan 1. Mol Ther. 2021. PMID: 33388418 Free PMC article.
References
-
- Cova D., De Angelis L., Monti E., Piccinini F. Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-induced cardiotoxicity. Free Radic. Res. Commun. 1992;15:353–360. - PubMed
-
- Haendeler J., Dröse S., Büchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009;29:929–935. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
